A gene expression signature that can predict green tea exposure and chemopreventive efficacy of lung cancer in mice.

Green tea has been shown to be a potent chemopreventive agent against lung tumorigenesis in animal models. Previously, we found that treatment of A/J mice with either green tea (0.6% in water) or a defined green tea catechin extract (polyphenon E; 2.0 g/kg in diet) inhibited lung tumor tumorigenesis. Here, we described expression profiling of lung tissues derived from these studies to determine the gene expression signature that can predict the exposure and efficacy of green tea in mice. We first profiled global gene expressions in normal lungs versus lung tumors to determine genes which might be associated with the tumorigenic process (TUM genes). Gene expression in control tumors and green tea-treated tumors (either green tea or polyphenon E) were compared to determine those TUM genes whose expression levels in green tea-treated tumors returned to levels seen in normal lungs. We established a 17-gene expression profile specific for exposure to effective doses of either green tea or polyphenon E. This gene expression signature was altered both in normal lungs and lung adenomas when mice were exposed to green tea or polyphenon E. These experiments identified patterns of gene expressions that both offer clues for green tea's potential mechanisms of action and provide a molecular signature specific for green tea exposure.

[1]  S. Amin,et al.  Inhibition of tobacco-specific nitrosamine-induced lung tumorigenesis in A/J mice by green tea and its major polyphenol as antioxidants. , 1992, Cancer research.

[2]  G. Kelloff Perspectives on cancer chemoprevention research and drug development. , 2000, Advances in cancer research.

[3]  Ross Ihaka,et al.  Gentleman R: R: A language for data analysis and graphics , 1996 .

[4]  M. Suganuma,et al.  Preventive effects of drinking green tea on cancer and cardiovascular disease: epidemiological evidence for multiple targeting prevention. , 2000, BioFactors.

[5]  H Ishii,et al.  Expression of mRNA for DNA methyltransferases and methyl‐CpG–binding proteins and DNA methylation status on CpG islands and pericentromeric satellite regions during human hepatocarcinogenesis , 2001, Hepatology.

[6]  A. Albini,et al.  Prostate carcinoma and green tea: (−)epigallocatechin‐3‐gallate inhibits inflammation‐triggered MMP‐2 activation and invasion in murine TRAMP model , 2004, International journal of cancer.

[7]  Andy H. Lee,et al.  Green tea consumption enhances survival of epithelial ovarian cancer , 2004, International journal of cancer.

[8]  Guoying Liu,et al.  NetAffx: Affymetrix probesets and annotations , 2003, Nucleic Acids Res..

[9]  M. You,et al.  A germ-line p53 mutation accelerates pulmonary tumorigenesis: p53-independent efficacy of chemopreventive agents green tea or dexamethasone/myo-inositol and chemotherapeutic agents taxol or adriamycin. , 2000, Cancer research.

[10]  S. Hirohashi,et al.  DNA methyltransferase expression and DNA methylation of CPG islands and peri‐centromeric satellite regions in human colorectal and stomach cancers , 2001, International journal of cancer.

[11]  Jill P. Mesirov,et al.  GeneCluster 2.0: an advanced toolset for bioarray analysis , 2004, Bioinform..

[12]  S. Lam,et al.  A Randomized Phase IIb Trial of Pulmicort Turbuhaler (Budesonide) in People with Dysplasia of the Bronchial Epithelium , 2004, Clinical Cancer Research.

[13]  P. Maliakal,et al.  Inhibition of carcinogenesis by tea. , 1997, Nature.

[14]  T. Speed,et al.  Summaries of Affymetrix GeneChip probe level data. , 2003, Nucleic acids research.

[15]  Ni Ai,et al.  Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. , 2003, Cancer research.

[16]  M. Sporn,et al.  Recent advances in chemoprevention of cancer. , 1997, Science.

[17]  U. Pastorino,et al.  Deletions of 17p and p53 mutations in preneoplastic lesions of the lung. , 1992, Cancer research.

[18]  S. Lam,et al.  A randomized phase IIb trial of anethole dithiolethione in smokers with bronchial dysplasia. , 2002, Journal of the National Cancer Institute.

[19]  Chi-Tang Ho,et al.  Green tea polyphenols , 2004 .

[20]  H. Mukhtar,et al.  Tea polyphenols: prevention of cancer and optimizing health. , 2000, The American journal of clinical nutrition.

[21]  M. You,et al.  Differential gene expression in chemically induced mouse lung adenomas. , 2003, Neoplasia.

[22]  A. Jemal,et al.  Cancer Statistics, 2005 , 2005, CA: a cancer journal for clinicians.

[23]  Clinical development plan: Tea extracts green tea polyphenols epigallocatechin gallate , 2002 .

[24]  Steven C. Lawlor,et al.  GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways , 2002, Nature Genetics.